In Vitro Diagnostic (IVD) Kit Market to Reach USD 120 Billion by 2033 at a 6.5% CAGR - SRI

London, UK - October 2026 | Strategic Revenue Insights Inc. - The rising prevalence of chronic and infectious diseases and advances in diagnostic technology are driving growth in in vitro diagnostic (IVD) kits. According to Strategic Revenue Insights, the global in vitro diagnostic (ivd) kit market is projected to reach USD 120 billion by 2033, registering a CAGR of 6.5% from 2025 to 2033. The report was prepared by lead analyst Kamrul Hasan. The source report does not disclose detailed methodology, including the number of primary interviews or the specific secondary datasets used.

Key Takeaways

• Market value is projected to reach USD 120 billion by 2033, at a CAGR of 6.5% from 2025 to 2033.
• Kits span clinical chemistry, immunoassay, molecular diagnostics, hematology, microbiology, and point-of-care testing.
• Molecular diagnostics such as PCR and next-generation sequencing, and companion diagnostics, are propelling growth.
• North America holds a dominant position, while Asia Pacific is expected to record the highest growth rate.
• Named market participants include Roche Diagnostics, Abbott Laboratories, and Siemens Healthineers.

Report URL: https://www.strategicrevenueinsights.com/industry/in-vitro-diagnostic-kit-market

Disease Burden and Diagnostic Advances Drive IVD Kit Growth

Growth is primarily driven by the increasing prevalence of chronic diseases and advancements in diagnostic technologies.

As the global population ages, conditions such as diabetes, cardiovascular disease, and cancer are rising, requiring early and accurate diagnosis. North America holds a dominant position thanks to well-established healthcare infrastructure, high healthcare expenditure, and a strong research focus.

Market Segmentation

By Clinical Chemistry: Basic Metabolic Panel, Liver Panel, Lipid Profile, and Thyroid Function Panel.

By Immunoassay: ELISA, Radioimmunoassay (RIA), Rapid Tests, and Western Blot.

By Molecular Diagnostics: PCR, Next-Generation Sequencing (NGS), Microarrays, and INAAT.

By Hematology: Complete Blood Count, Hemoglobin A1c, Coagulation Tests, and Blood Typing.

By Microbiology: Bacterial Culture, Viral Culture, Parasitology, and Mycology.

By Point of Care Testing: Glucose Monitoring, Pregnancy Testing, Infectious Disease Testing, and Cardiac Markers. The source does not identify a largest segment.

Regional Outlook

The report covers North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America holds a dominant position in the market, driven by well-established healthcare infrastructure and high healthcare expenditure, while the Asia Pacific region is expected to witness the highest growth rate. The source provides no further region-specific market values or growth rates.

Competitive Landscape

The report names Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Thermo Fisher Scientific, Danaher Corporation, Becton, Dickinson and Company, Bio-Rad Laboratories, Qiagen N.V., Sysmex Corporation, bioMérieux SA, Hologic, Inc., and Ortho Clinical Diagnostics as market participants.

Market Restraints

Stringent regulatory requirements for the approval and use of IVD kits are a primary challenge for manufacturers in terms of compliance and time to market.

Related Reports

https://www.strategicrevenueinsights.com/industry/hearing-loss-treatment-device-market

https://www.strategicrevenueinsights.com/industry/absorbable-bone-nail-market

https://www.strategicrevenueinsights.com/industry/epileptic-seizure-monitoring-system-market

https://www.strategicrevenueinsights.com/industry/transcranial-stimulator-market

https://www.strategicrevenueinsights.com/industry/dental-devices-and-consumable-market

https://www.strategicrevenueinsights.com/industry/orthopedics-plates-and-screws-market

https://www.strategicrevenueinsights.com/industry/blood-purification-device-market

https://www.strategicrevenueinsights.com/industry/sheath-introducer-market

https://www.strategicrevenueinsights.com/industry/icu-patient-monitor-market

https://www.strategicrevenueinsights.com/industry/kidney-machines-market

Frequently Asked Questions

What will be the market size by 2033?

The market is projected to reach USD 120 billion by 2033.

What is the expected CAGR of the in vitro diagnostic (ivd) kit market?

The market is projected to expand at a CAGR of 6.5% from 2025 to 2033.

Which segment is largest in the in vitro diagnostic (ivd) kit market?

The source does not identify a largest segment.

Which region leads the in vitro diagnostic (ivd) kit market?

North America holds a dominant position in the market, driven by well-established healthcare infrastructure and high healthcare expenditure, while the Asia Pacific region is expected to witness the highest growth rate.

About Strategic Revenue Insights Inc.

Strategic Revenue Insights Inc., part of SRI Consulting Group Ltd, is a London-headquartered market intelligence firm that helps organizations across industries and geographies make evidence-based revenue and strategy decisions. The firm produces syndicated research reports and customized consulting engagements built on rigorous market sizing, forecasting, and competitive benchmarking, drawing on a globally connected team of analysts and consultants.

Media Contact Information

Company Name: Strategic Revenue Insights Inc.

Contact Person: Rohit Bhisey

Email: sales@strategicrevenueinsights.com

Phone: +44-787-740-3352

Address: Suite 10, Capital House, 61 Amhurst Road, London, E8 1LL, United Kingdom

Corporate Websites:

www.strategicrevenueinsights.com

www.strategicpackaginginsights.com

www.sriconsultinggroupltd.com

https://strategicrevenueinsights.blog/

https://medium.com/@strategic-revenue-insights.inc

https://www.strategicrevenueinsights.com/press-releases